Ingo Weigmann

3.8k total citations
4 papers, 30 citations indexed

About

Ingo Weigmann is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Nephrology. According to data from OpenAlex, Ingo Weigmann has authored 4 papers receiving a total of 30 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Cardiology and Cardiovascular Medicine, 1 paper in Molecular Biology and 1 paper in Nephrology. Recurrent topics in Ingo Weigmann's work include Angiogenesis and VEGF in Cancer (1 paper), Blood properties and coagulation (1 paper) and Retinal Imaging and Analysis (1 paper). Ingo Weigmann is often cited by papers focused on Angiogenesis and VEGF in Cancer (1 paper), Blood properties and coagulation (1 paper) and Retinal Imaging and Analysis (1 paper). Ingo Weigmann collaborates with scholars based in Germany and United Kingdom. Ingo Weigmann's co-authors include Andreas L. Birkenfeld, M Hanefeld, Frank Pistrosch, Dorothea Schipp, Stefan R. Bornstein, Jan Sradnick, Elena Henkel, Bernhard Schipp, W.M. Herrmann and B Terhaag and has published in prestigious journals such as PLoS ONE, Diabetologia and International Journal of Clinical Pharmacology and Therapeutics.

In The Last Decade

Ingo Weigmann

4 papers receiving 28 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ingo Weigmann Germany	3	17	8	7	7	5	4	30
Priit Pauklin Estonia	3	36 2.1×	9 1.1×	10 1.4×	3 0.4×	3 0.6×	5	50
Karolina Marzec Poland	4	17 1.0×	5 0.6×	4 0.6×	4 0.6×	3 0.6×	6	30
S. Thomas United States	2	23 1.4×	2 0.3×	8 1.1×	12 1.7×	5 1.0×	2	31
Levent Korkmaz Türkiye	4	14 0.8×	5 0.6×	5 0.7×		3 0.6×	5	35
Н. А. Новикова Russia	3	17 1.0×	6 0.8×	4 0.6×	3 0.4×	1 0.2×	18	31
Clara Podmore Switzerland	3	9 0.5×	6 0.8×	2 0.3×	6 0.9×	8 1.6×	5	33
T. Sawadogo France	3	14 0.8×	9 1.1×	10 1.4×	10 1.4×	1 0.2×	4	37
I. Guerreiro Portugal	4	7 0.4×	3 0.4×	7 1.0×	12 1.7×	7 1.4×	11	24
Eric Van Belle France	4	12 0.7×	6 0.8×	7 1.0×	2 0.3×		5	27
Luting Xue United States	3	13 0.8×	6 0.8×	2 0.3×	4 0.6×	4 0.8×	3	30

Countries citing papers authored by Ingo Weigmann

Since Specialization

Citations

This map shows the geographic impact of Ingo Weigmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingo Weigmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingo Weigmann more than expected).

Fields of papers citing papers by Ingo Weigmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingo Weigmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingo Weigmann. The network helps show where Ingo Weigmann may publish in the future.

Co-authorship network of co-authors of Ingo Weigmann

This figure shows the co-authorship network connecting the top 25 collaborators of Ingo Weigmann. A scholar is included among the top collaborators of Ingo Weigmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingo Weigmann. Ingo Weigmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Pistrosch, Frank, Dorothea Schipp, Bernhard Schipp, et al.. (2021). Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers. Diabetologia. 64(12). 2701–2712. 15 indexed citations

2.

Hanefeld, M, Katrin Engelmann, Dirk Sandner, et al.. (2017). Intra-individual variability and circadian rhythm of vascular endothelial growth factors in subjects with normal glucose tolerance and type 2 diabetes. PLoS ONE. 12(10). e0184234–e0184234. 11 indexed citations

3.

Faulhaber, Hans‐Dieter, Ingo Weigmann, Undine E. Lang, Frank Weinsberg, & B Terhaag. (2005). Anti-anginal and anti-ischemic effects of the selective b-blocker talinolol in patients with stable angina pectoris. International Journal of Clinical Pharmacology and Therapeutics. 43(2). 63–70. 1 indexed citations

4.

Weigmann, Ingo, B Terhaag, W Wierich, & W.M. Herrmann. (1998). [Antihypertensive action of various talinolol dosages after four week's treatment in comparison with placebo].. PubMed. 48(3). 240–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact